Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2df2e1189fa8605916aa5ef7b6df8f95 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
filingDate |
2018-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86b0a283003cc1996e001883c7db58d2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6a9962c6379791214037736c046c01d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8581dd3aaa7c789b07880cd9301fcb8d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a9ab7867245e0ae2b3e7ab5be1dd988 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1593608b28d73a477d61e4669c1afb92 |
publicationDate |
2021-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2021130358-A1 |
titleOfInvention |
Pyrrolotriazine Derivatives as Kinase Inhibitor |
abstract |
The present invention relates to a compound represented by the Chemical Formula 1 defined in the present specification, or a pharmaceutically acceptable salt thereof. The compound according to the present invention can be usefully used for the prevention or treatment of diseases which are associated with kinase inhibitory actions. |
priorityDate |
2017-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |